Cited by 221Fibromyalgia and Chronic Fatigue Syndrome ResearchLong-Term Effects of COVID-19Viral-associated cancers and disorders

Chronic fatigue syndrome after infectious mononucleosis in adolescents

Open access
Katz, Ben Z., Shiraishi, Yukiko, Mears, Cynthia J., Binns, Helen J., Taylor, Renee·2009·PEDIATRICS

Abstract

OBJECTIVE: The goal was to characterize prospectively the course and outcome of chronic fatigue syndrome in adolescents during a 2-year period after infectious mononucleosis. METHODS: A total of 301 adolescents (12-18 years of age) with infectious mononucleosis were identified and screened for nonrecovery 6 months after infectious mononucleosis by using a telephone screening interview. Nonrecovered adolescents underwent a medical evaluation, with follow-up screening 12 and 24 months after infectious mononucleosis. After blind review, final diagnoses of chronic fatigue syndrome at 6, 12, and 24 months were made by using established pediatric criteria. RESULTS: Six, 12, and 24 months after infectious mononucleosis, 13%, 7%, and 4% of adolescents, respectively, met the criteria for chronic fatigue syndrome. Most individuals recovered with time; only 2 adolescents with chronic fatigue syndrome at 24 months seemed to have recovered or had an explanation for chronic fatigue at 12 months but then were reclassified as having chronic fatigue syndrome at 24 months. All 13 adolescents with chronic fatigue syndrome 24 months after infectious mononucleosis were female and, on average, they reported greater fatigue severity at 12 months. Reported use of steroid therapy during the acute phase of infectious mononucleosis did not increase the risk of developing chronic fatigue syndrome. CONCLUSIONS: Infectious mononucleosis may be a risk factor for chronic fatigue syndrome in adolescents. Female gender and greater fatigue severity, but not reported steroid use during the acute illness, were associated with the development of chronic fatigue syndrome in adolescents. Additional research is needed to determine other predictors of persistent fatigue after infectious mononucleosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1542/peds.2008-1879

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Women are at higher risk of ME/CFS than men.

    “Since women are at higher risk of ME/CFS than men5,18, it is thought that female sex hormones play an important role in the onset, persistence, and symptom burden of this illness19.”

    From Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically-relevant Phenotyping of Women with Chronic Fatigue Syndrome (2019) · cites this paper as [5]

    The Results report that 35 of 39 adolescents with CFS six months after infectious mononucleosis were female, and the Discussion says females may be at particular risk. This supports a sex difference in the studied post-infection adolescent cohort, but not the broader claim that women generally have a higher risk of ME/CFS than men. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Katz, B. Z., Shiraishi, Y., Mears, C. J., Binns, H. J., & Taylor, R.
Affiliations
  • Northwestern University (US)
  • University of Illinois Chicago (US)
  • Department of Occupational Health, College of Applied Sciences, University of Illinois at Chicago, Chicago, Illinois
Venue
PEDIATRICS
Published
2009-07-01
Volume
124
Issue
1
Pages
189-193
ISSN
  • 0031-4005 (ISSN-L)
  • 1098-4275
OpenAlex
W2021748243
Cited by
221
References
19
Citations by year
2026: 9 · 2025: 15 · 2024: 23 · 2023: 25 · 2022: 26 · 2021: 19 · 2020: 11 · 2019: 18 · 2018: 10 · 2017: 11 · 2016: 12 · 2015: 4 · 2014: 11 · 2013: 4 · 2012: 8
FWCI
4.54
Type
journal article
Language
en
Open access
Locations
  • PEDIATRICS (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • University of Illinois at Urbana-Champaign
  • National Institute of Child Health and Human Development
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD043301, R01HD4330101A1)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
  • Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
Keywords
chronic fatigue syndrome, infectious mononucleosis, adolescents, persistent fatigue, corticosteroid therapy, female sex, fatigue severity, risk factors, post-infectious fatigue
MeSH terms
Adolescent, Child, Female, Humans, Infectious Mononucleosis, Male, Risk Factors, Fatigue Syndrome, Chronic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review